TopFunds

Cigna

NYSE: CI

Stock price

298.77 USD

(+0%) TODAY

Health Care ServicesMedical - Healthcare Plans
Financials

all figures in US$ Millions except per share data

Sections:

Periods:

View:

Format:

Actual
10 year cagr
Help
Where available up to 10y CAGR shown for absolute numbers 10y Average marked A shown for relative numbers such as margins
Fiscal
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Average (A)
Fiscal period end dates
Expand all rows
01Earnings per share
Help
Earnings per share = Net Income / Number of Shares Outstanding
8
7.2
9.2
10.5
13.4
23
15.8
21.4
17.4
12.1
22.2
10.7%
02Free cash flow per share
9.3
13.7
14.8
13.1
22.2
25.1
17.7
23.5
34.5
31.6
31.5
13%
03Dividends per share
-
-
-
-
-
-
4
4.5
4.9
5.6
6
65.2%
04Dividends payout, %
0.5%
0.6%
0.4%
0.4%
0.3%
0.2%
25%
20.6%
28.1%
45.6%
27%
49.4%
PROFIT AND LOSS STATEMENT
05Revenue
$ 37,876
$ 39,838
$ 41,806
$ 48,650
$ 153,566
$ 160,401
$ 174,069
$ 180,518
$ 195,265
$ 247,121
$ 274,952
21.9%
06% Change
-
5.2%
4.9%
16.4%
215.7%
4.5%
8.5%
3.7%
8.2%
26.6%
11.3%
21.9%
07Cost of revenue
(25,424)
(26,809)
(27,719)
(32,321)
(128,487)
(136,194)
(151,118)
(157,018)
(170,088)
(221,157)
(248,966)
25.6%
08Gross profit
12,452
13,029
14,087
16,329
25,079
24,207
22,951
23,500
25,177
25,964
25,986
7.6%
09% Margin
32.9%
32.7%
33.7%
33.6%
16.3%
15.1%
13.2%
13%
12.9%
10.5%
9.5%
20.3% A
10Operating expenses
(92)
(9,941)
(10,145)
(12,169)
(17,002)
(16,054)
(15,010)
(15,050)
(16,641)
(16,547)
(16,857)
68.4%
11% of Revenue
(0.2)%
(25)%
(24.3)%
(25)%
(11.1)%
(10)%
(8.6)%
(8.3)%
(8.5)%
(6.7)%
(6.1)%
(12.2)% A
12Operating Income
12,360
3,088
3,942
4,160
8,077
8,153
7,941
8,450
8,536
9,417
9,129
(3)%
13Income tax expense
(1,250)
(1,136)
(1,374)
(935)
(1,450)
(2,379)
(1,370)
(1,615)
(141)
(1,491)
(1,345)
0.7%
14Net Income
2,094
1,867
2,237
2,637
5,104
8,458
5,370
6,704
5,164
3,434
5,957
11%
15% Margin
5.5%
4.7%
5.4%
5.4%
3.3%
5.3%
3.1%
3.7%
2.6%
1.4%
2.2%
3.9% A
16Shares Outstanding
260,592
259,647
243,967
246,652
379,817
368,389
340,966
313,065
296,882
283,218
265,948
0.2%
17EPS Basic
8.2
7.3
9.2
10.7
13.6
23.2
15.9
21.7
17.6
12.3
22.3
10.6%
18EPS Diluted
8
7.2
9.2
10.5
13.4
23
15.8
21.4
17.4
12.1
22.2
10.7%
19EBITDA
4,078
3,862
4,692
5,559
12,466
11,367
11,085
11,516
12,069
12,467
11,749
11.2%
% Margin
10.8%
9.7%
11.2%
11.4%
8.1%
7.1%
6.4%
6.4%
6.2%
5%
4.3%
7.9% A
20Net Interest Income (expense)
-
(278)
(252)
(498)
(1,682)
(1,438)
(1,208)
(1,228)
(1,446)
(1,435)
(1,381)
-
21Net Debt / EBITDA
0.8
0.5
0.5
6.9
2.7
2.1
2.6
2.2
1.9
2
2
2.2 A
BALANCE SHEET
ASSETS
Current Assets
22Cash & equivalents
1,968
3,185
2,972
3,855
4,619
10,182
5,081
5,924
7,822
7,550
7,676
14.6%
23Short-term investments
381
691
2,136
2,045
937
1,331
920
905
925
665
-
-
24Accounts receivable
3,560
3,025
2,904
10,197
10,382
11,999
14,615
16,970
17,450
24,065
28,768
23.2%
25Other current assets
7,854
6,530
1,071
1,512
11,246
1,122
11,796
1,546
5,509
9,898
4,032
(6.5)%
26Inventory
-
-
228
2,821
2,661
3,165
3,722
4,777
5,645
6,692
7,338
-
27Total Current Assets
13,763
13,431
9,311
20,430
29,845
27,799
36,134
30,122
37,351
48,870
47,814
13.3%
Non-Current Assets
28Net property, plant & equipment
800
767
756
1,283
1,752
1,744
1,664
1,301
877
828
3,651
16.4%
29Long-term investments
23,518
25,386
26,483
26,929
21,493
23,199
18,396
16,236
17,985
15,128
18,471
(2.4)%
30Other non-current assets
19,007
19,776
25,209
104,584
102,684
102,709
98,695
96,226
96,548
91,055
87,983
16.6%
31Total Non-Current Assets
43,325
45,929
52,448
132,796
125,929
127,652
118,755
113,763
115,410
107,011
110,105
9.8%
Total Assets
57,088
59,360
61,759
153,226
155,774
155,451
154,889
143,885
152,761
155,881
157,919
10.7%
LIABILITIES
Current Liabilities
32Accounts payable
4,655
5,452
489
15,068
15,544
18,825
21,964
24,845
28,368
37,759
10,659
8.6%
33Short-term debt
149
276
240
2,955
5,680
3,526
2,704
3,107
2,775
3,035
592
14.8%
34Other current liabilities
1,013
2,532
10,280
13,872
18,914
13,671
18,904
13,273
17,573
17,185
45,091
46.2%
35Total Current Liabilities
5,817
8,260
11,009
31,895
40,138
36,022
43,572
41,225
48,716
57,979
56,342
25.5%
Non-Current Liabilities
36Long-term debt
5,020
4,756
5,199
39,523
32,358
30,036
31,561
28,446
28,155
28,937
30,939
19.9%
37Other non-current liabilities
34,138
32,559
31,791
40,736
37,899
39,007
32,572
29,460
29,539
27,722
28,764
(1.7)%
38Total Non-Current Liabilities
39,158
37,315
36,990
80,259
70,257
69,043
64,133
57,906
57,694
56,659
59,703
4.3%
39Total Liabilities
44,975
45,575
47,969
112,154
110,395
105,065
107,705
98,981
106,410
114,638
116,045
9.9%
SHAREHOLDERS` EQUITY
40Common stock
74
74
74
4
4
4
4
4
4
4
4
(25.3)%
41Retained earnings / (deficit)
12,121
13,855
15,824
15,088
20,162
28,575
32,593
37,874
41,652
43,519
47,865
14.7%
42Accumulated other comprehensive income / (loss)
(1,250)
(1,382)
(1,082)
(1,711)
(941)
(861)
(884)
(1,395)
(1,864)
(2,341)
(2,806)
8.4%
43Noncontrolling interests
78
62
49
44
41
65
72
79
128
210
161
7.5%
44Total shareholders' equity
12,113
13,785
13,784
41,072
45,379
50,386
47,184
44,951
46,351
41,243
41,874
13.2%
45Total Liabilities and shareholders' Equity
57,088
59,360
61,753
153,226
155,774
155,451
154,889
143,885
152,761
155,881
157,919
10.7%
46Total Debt
5,169
5,032
5,439
42,478
38,038
33,562
34,265
31,553
30,930
31,972
31,463
19.8%
47Net Debt
3,201
1,847
2,467
38,623
33,419
23,380
29,184
25,629
23,108
24,422
23,787
22.2%
CASH FLOW STATEMENT
CASH FLOWS FROM OPERATING ACTIVITIES
48Net income (loss)
2,094
1,867
2,237
2,637
5,104
8,458
5,370
6,704
5,164
3,434
5,957
11%
49Depreciation & amortization
585
610
566
695
3,651
2,802
2,923
2,937
3,035
2,775
2,775
16.9%
50Share-based compensation expense
-
-
-
-
-
-
-
-
-
-
-
-
51Changes in working capital and other assets
254
1,549
1,283
438
730
(910)
(1,102)
(985)
3,614
4,154
869
13.1%
52Net cash flows from operating activities
2,933
4,026
4,086
3,770
9,485
10,350
7,191
8,656
11,813
10,363
9,601
12.6%
CASH FLOWS FROM INVESTING ACTIVITIES
53Purchases of property, plant and equipment
(510)
(461)
(471)
(528)
(1,050)
(1,094)
(1,154)
(1,295)
(1,573)
(1,406)
(1,212)
9%
54Purchases of investments / marketable securities
(5,417)
(6,889)
(6,693)
(6,826)
(6,035)
(6,689)
(6,107)
(4,319)
(5,539)
(2,695)
(7,204)
2.9%
55Proceeds from maturities of marketable securities
4,150
4,730
5,765
5,540
6,623
5,377
5,594
4,110
2,636
2,447
2,652
(4.4)%
56Other investing activities
41
46
(304)
(24,564)
(272)
5,382
(1,944)
4,602
(698)
(448)
1,357
41.9%
57Net cash flows from investing activities
(1,736)
(2,574)
(1,703)
(26,378)
(734)
2,976
(3,611)
3,098
(5,174)
(2,102)
(4,407)
9.8%
CASH FLOWS FROM FINANCING ACTIVITIES
58Issuance (repurchases) of common stock, net
(517)
(103)
(2,594)
(274)
(1,763)
(3,666)
(7,416)
(7,218)
(2,097)
(6,729)
(3,418)
20.8%
59Dividends paid, net
-
-
-
-
(15)
(15)
(1,341)
(1,384)
(1,450)
(1,567)
(1,611)
-
60Debt issuance (repayments), net
22
(148)
411
24,212
(5,172)
(4,524)
657
(2,559)
(278)
1,060
(666)
-
61Other financing activities
(35)
26
(468)
(423)
(237)
(328)
(112)
(79)
(469)
(411)
(726)
35.4%
62Net cash flows from financing activities
(530)
(225)
(2,651)
23,515
(7,187)
(8,533)
(8,212)
(11,240)
(4,294)
(7,647)
(6,421)
28.3%
63Increase (decrease) in cash and cash equivalents
548
1,217
(213)
883
1,556
4,834
(4,697)
428
2,361
594
126
(13.7)%
64Cash and equivalents, ending balance
1,968
3,185
2,972
3,855
5,411
10,245
5,548
5,976
8,337
8,931
7,676
14.6%
65Free Cash Flow to the Firm (FCFF)
Help
Free Cash Flow to the Firm = Cash Flows from Operating Activities - Capital Expenditures
2,423
3,565
3,615
3,242
8,435
9,256
6,037
7,361
10,240
8,957
8,389
13.2%

Annual Reports, Presentations And IR Contacts

Go to the website
Annual report links (10K)
20252024202320222021202020192018

Cigna (CI) financial statements and performance

Explore Cigna (CI) annual and quarterly financial statements, including revenue, operating income, net income, cash flow, assets, liabilities, and per-share metrics.

Compare reporting periods and financial trends to evaluate profitability, balance-sheet strength, cash generation, and long-term business performance.